1Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea.
2Medical Research Collaborating Center, Seoul National University Hospital, Seoul, Korea.
Copyright © 2012 The Korean Society for Preventive Medicine
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Hypnotics | No. of hazard period expo- sures (n = 1508) | No. of control period expo- sures (n = 6032) | Crude OR (95% CI) | Adjusted OR1 (95% CI) |
---|---|---|---|---|
Zolpidem | 236 | 722 | 1.84 (1.47, 2.30) | 1.72 (1.37, 2.16) |
Benzodiazepin hypnotics | 364 | 1394 | 1.12 (0.93, 1.34) | 1.00 (0.83, 1.21) |
Triazolam | 203 | 765 | 1.15 (0.91, 1.47) | 1.04 (0.82, 1.33) |
Lorazepam | 146 | 550 | 1.17 (0.87, 1.58) | 1.06 (0.79, 1.44) |
Flurazepam | 23 | 101 | 0.85 (0.48, 1.54) | 0.73 (0.41, 1.31) |
Flunitrazepam | 25 | 108 | 0.81 (0.40, 1.66) | 0.78 (0.38, 1.58) |
Midazolam | 3 | 15 | 0.69 (0.15, 3.30) | 0.60 (0.12, 2.92) |
Brotizolam | 7 | 27 | 1.07 (0.35, 3.31) | 0.97 (0.31, 2.97) |